Literature DB >> 23744793

Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis.

Scott B Reeder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23744793      PMCID： PMC5423437          DOI： 10.1002/hep.26543

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  19 in total

1.  Relaxation effects in the quantification of fat using gradient echo imaging.

Authors:  Mark Bydder; Takeshi Yokoo; Gavin Hamilton; Michael S Middleton; Alyssa D Chavez; Jeffrey B Schwimmer; Joel E Lavine; Claude B Sirlin
Journal:  Magn Reson Imaging       Date:  2008-02-21       Impact factor: 2.546

2.  Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise.

Authors:  Chia-Ying Liu; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2007-08       Impact factor: 4.668

3.  T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis.

Authors:  Catherine D G Hines; Alex Frydrychowicz; Gavin Hamilton; Dana L Tudorascu; Karl K Vigen; Huanzhou Yu; Charles A McKenzie; Claude B Sirlin; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

4.  Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse.

Authors:  Catherine D G Hines; Rashmi Agni; Calista Roen; Ian Rowland; Diego Hernando; Eric Bultman; Debra Horng; Huanzhou Yu; Ann Shimakawa; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2011-11-29       Impact factor: 4.813

5.  Addressing phase errors in fat-water imaging using a mixed magnitude/complex fitting method.

Authors:  D Hernando; C D G Hines; H Yu; S B Reeder
Journal:  Magn Reson Med       Date:  2011-06-28       Impact factor: 4.668

6.  Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction.

Authors:  Huanzhou Yu; Ann Shimakawa; Catherine D G Hines; Charles A McKenzie; Gavin Hamilton; Claude B Sirlin; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2011-02-24       Impact factor: 4.668

Review 7.  Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.

Authors:  Karima Begriche; Julie Massart; Marie-Anne Robin; Annie Borgne-Sanchez; Bernard Fromenty
Journal:  J Hepatol       Date:  2010-11-17       Impact factor: 25.083

8.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

9.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

10.  T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO phantom.

Authors:  Catherine D G Hines; Huanzhou Yu; Ann Shimakawa; Charles A McKenzie; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2009-11       Impact factor: 4.813
View more
  24 in total

1.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

2.  Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.

Authors:  Camilo A Campo; Diego Hernando; Tilman Schubert; Candice A Bookwalter; Andrew J Van Pay; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2017-07-13       Impact factor: 3.959

3.  Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis.

Authors:  Guido M Kukuk; Kanishka Hittatiya; Alois M Sprinkart; Holger Eggers; Jürgen Gieseke; Wolfgang Block; Philipp Moeller; Winfried A Willinek; Ulrich Spengler; Jonel Trebicka; Hans-Peter Fischer; Hans H Schild; Frank Träber
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

4.  Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study.

Authors:  Amir Zarrinpar; Shakti Gupta; Mano R Maurya; Shankar Subramaniam; Rohit Loomba
Journal:  Gut       Date:  2015-05-22       Impact factor: 23.059

Review 5.  Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.

Authors:  Jiulian Gu; Shousheng Liu; Shuixian Du; Qing Zhang; Jianhan Xiao; Quanjiang Dong; Yongning Xin
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

6.  Quantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI.

Authors:  Utaroh Motosugi; Diego Hernando; Peter Bannas; James H Holmes; Kang Wang; Ann Shimakawa; Yuji Iwadate; Valentina Taviani; Jennifer L Rehm; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2015-04-01       Impact factor: 4.813

7.  Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.

Authors:  Jeffrey Cui; Len Philo; Phirum Nguyen; Heather Hofflich; Carolyn Hernandez; Ricki Bettencourt; Lisa Richards; Joanie Salotti; Archana Bhatt; Jonathan Hooker; William Haufe; Catherine Hooker; David A Brenner; Claude B Sirlin; Rohit Loomba
Journal:  J Hepatol       Date:  2016-05-02       Impact factor: 25.083

8.  Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.

Authors:  Cyrielle Caussy; Meera Soni; Jeffrey Cui; Ricki Bettencourt; Nicholas Schork; Chi-Hua Chen; Mahdi Al Ikhwan; Shirin Bassirian; Sandra Cepin; Monica P Gonzalez; Michel Mendler; Yuko Kono; Irine Vodkin; Kristin Mekeel; Jeffrey Haldorson; Alan Hemming; Barbara Andrews; Joanie Salotti; Lisa Richards; David A Brenner; Claude B Sirlin; Rohit Loomba
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

Review 9.  Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ma Ai Thanda Han; Rola Saouaf; Walid Ayoub; Tsuyoshi Todo; Edward Mena; Mazen Noureddin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-03-09       Impact factor: 5.045

10.  Validation of goose liver fat measurement by QCT and CSE-MRI with biochemical extraction and pathology as reference.

Authors:  Li Xu; Yangyang Duanmu; Glen M Blake; Chenxin Zhang; Yong Zhang; Keenan Brown; Xiaoqi Wang; Peng Wang; Xingang Zhou; Manling Zhang; Chao Wang; Zhe Guo; Giuseppe Guglielmi; Xiaoguang Cheng
Journal:  Eur Radiol       Date:  2017-12-13       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.